165 related articles for article (PubMed ID: 36788389)
21. Can we detect biomarkers of oral squamous cell carcinoma from saliva or mouth swabs?
Gaw G; Gribben M
Evid Based Dent; 2022 Mar; 23(1):32-33. PubMed ID: 35338327
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
24. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
25. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
Xiao T; Lin F; Zhou J; Tang Z
Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
[TBL] [Abstract][Full Text] [Related]
27. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
28. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
29. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
Rivera C; Oliveira AK; Costa RAP; De Rossi T; Paes Leme AF
Oral Oncol; 2017 Sep; 72():38-47. PubMed ID: 28797460
[TBL] [Abstract][Full Text] [Related]
30. Malondialdehyde, an Oxidative Stress Marker in Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohideen K; Sudhakar U; Balakrishnan T; Almasri MA; Al-Ahmari MM; Al Dira HS; Suhluli M; Dubey A; Mujoo S; Khurshid Z; Raj AT; Patil S
Curr Issues Mol Biol; 2021 Aug; 43(2):1019-1035. PubMed ID: 34563041
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic significance of p27 expression in oral squamous cell carcinoma: a meta-analysis.
Gao L; Gu W; Zheng J; Ren W; Chang S; Wang X; Li S; Song T; Huang C; Zhi K
Int J Biol Markers; 2013 Dec; 28(4):e329-35. PubMed ID: 23787492
[TBL] [Abstract][Full Text] [Related]
33. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
Khan S; Alamgir MM
J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells and stemness markers in oral squamous cell carcinomas.
Patel SS; Shah KA; Shah MJ; Kothari KC; Rawal RM
Asian Pac J Cancer Prev; 2014; 15(20):8549-56. PubMed ID: 25374166
[TBL] [Abstract][Full Text] [Related]
35. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
[TBL] [Abstract][Full Text] [Related]
36. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
38. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
[TBL] [Abstract][Full Text] [Related]
40. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
